Navigation Links
WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals

SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic physicians surveyed in September 2008. These companies are most noted for their knowledgeable, respectful and informed sales representatives, their sampling/voucher plans, and their educational resources, as well as their drug products.

"While Pfizer, Lilly and Endo may be the most appreciated companies among many of the surveyed pain clinicians, there is plenty of opportunity for others to enhance their company image," stated Susan Olsen, President of WWMR, Inc. "A notable proportion of the pain clinicians surveyed noted that they don't appreciate any pain drug companies, and we view this is an opportunity waiting." Clients subscribing to the Pain Clinic Monitor have full access to this company image information, which outlines opportunities for companies to develop positive relationships with clinicians, and profiles competing companies.

Launched in January 2008, the Pain Clinic Monitor provides deep insights into the treatment of pain clinic-based chronic pain patients. The Pain Clinic Monitor provides a long-awaited perspective on the treatment of more than 10,000 patients with 27 different pain conditions. Information is available on in-office treatments as well as on up to seven pain drugs a patient has been prescribed, including why prescribed drugs have been tried, switched and discontinued.

The Pain Clinic Monitor is a monthly audit of a carefully balanced sample of 100 academic and nonacademic, office-based pain clinics, with each reporting treatment details for 10 patients. It is the basis for the 27 pain condition profiles provided as part of the Monitor. Companies, drug products and detailing messages are also captured, as the clinicians report on detailing visits for up to five company sales representatives each month.

"There has been a major gap in resources that report to the biotech, pharmaceutical and medical device industries about prescription drug use and pharmaceutical marketing in pain clinics. The Pain Clinic Monitor is designed to fill this gap. The Pain Clinic Monitor presents a fresh, unique focus on point of care pain prescribing, and a significant opportunity to obtain actionable findings for Product Development, as well as Marketing and Physician Education professionals," stated Susan Olsen, President, WWMR. "There are no other comparable audits available to companies focused on the treatment of pain."

Some of the reasons companies subscribe to the Pain Clinic Monitor include:

    1.  Provides insights from a 10,000 pain-patient database;
    2.  Understanding drug use for 27 different pain conditions;
    3.  Monitor uptake of NEW pain drugs;
    4.  Track reasons for pain drug discontinuations;
    5.  Examine in-office (IV, injectable, oral and topical) pain drug
    6.  Know all the pain drugs a given chronic pain patient is taking;
    7.  Analyze pain drug detailing & detailing messages;
    8.  Profile competitive pain drug uses;
    9.  Connect with the most influential clinicians prescribing for chronic
        pain patients;
    10. Ask ad-hoc questions of a representative panel of pain center
    11. Support their company's product development, marketing, and physician
        education efforts in the pain therapy area; and
    12. Receive the results of the annual "Most Appreciated Pain Drug Company

WWMR, Inc. is a marketing research and strategic consulting and publishing firm with global capabilities, known for conducting focused and solution-oriented research across all phases of drug development. In addition to offering the Pain Clinic Monitor, the firm continues to expand its line of pain-related, multi-client Enhanced Perspective publications, with its 2008 U.S. Neuropathic Pain Report, featuring two new chapters -- Fibromyalgia and Neuropathic Cancer Pain. Two additional pain-related reports are scheduled to be available soon: Cancer Pain in December 2008 and Back Pain in January 2009. With an experienced staff of consultants and analysts, WWMR, Inc. continues to demonstrate its commitment to providing cost-effective business decision support to pharmaceutical, biotech, medical device and diagnostics clients who want to optimize the revenue potential of their product portfolio through effective business decisions.

For more information about the Pain Clinic Monitor and other services provided by WWMR, Inc., please contact Michelle Nordstrom, Office and Production Manager at the Corporate Headquarters:

     WWMR, Inc.
     2929 Campus Drive
     Suite 200
     San Mateo, CA 94403
     Phone: (888) 947-2339
            (650) 513-0300
     Fax:   (650) 312-1570

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wound Management Technologies, Inc. Announces a Published Case Study
2. Histogen Announces Start of Hair Regrowth Clinical Evaluation
3. New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida
4. KGI Announces Second Annual Executive Education Conference for Women in Life Sciences
5. SyntheMed Announces FDA Clearance of SinusShield(TM)
6. Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit
7. American HealthChoice Announces the First Sales of the OmniBody Scan
8. Tengion Announces Second Closing of Series C Financing
9. Penguin Computing Announces Niveus HTX Personal Supercomputer
10. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
11. BBM Announces Offer to Acquire YM BioSciences Inc.
Post Your Comments:
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  Twist Bioscience, a ... Emily Leproust , Ph.D., has been selected as one ... 2015 for fast-tracking the building blocks of life . ... Global Thinkers whose contributions and work have changed lives ... --> "It is an honor to be recognized ...
(Date:12/1/2015)... SAN DIEGO , Dec. 1, 2015 /PRNewswire/ ... that uses allogeneic stem cells for cardiovascular indications, ... clinical trial protocol based on recommendations from a ... leaders and its Scientific Advisory Board members ... boards analyzed preliminary Phase IIa safety and efficacy ...
(Date:12/1/2015)... Cepheid (Nasdaq: CPHD ) today announced ... Jaffray Healthcare Conference in New York City ... its outlook for the fourth quarter of 2015 and ... longer term business model expectations. John Bishop ... to be the fastest growing company of the major ...
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... practitioners and aesthetics professionals from Central America and abroad for the first Iberoamerican ... City, Panama Feb. 17-19, 2016. Testart will present and discuss new trends in ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/9/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), the ... entry into the automotive market with a comprehensive and ... of consumer electronics human interface innovation. Synaptics, industry-leading touch ... the automotive industry and will be implemented in numerous ... , Japan , and ...
(Date:10/29/2015)... 29, 2015   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that it ... (MHTA) as one of only three finalists for a ... Small and Growing" category. The Tekne Awards honor ... superior technology innovation and leadership. iMedNet™ ...
Breaking Biology News(10 mins):